Piper Jaffray Starts AVI BioPharma (AVII) at Overweight, $3.50 Price Target
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray initiated coverage on shares of AVI BioPharma (NASDAQ: AVII) with an Overweight rating and a $3.50 price target.
With shares of AVI closing just under $1.62 on Monday, Piper Jaffray's new price target suggests potential upside of about 117 percent.
For more ratings news on AVI BioPharma click here and for the rating history of AVI BioPharma click here.
With shares of AVI closing just under $1.62 on Monday, Piper Jaffray's new price target suggests potential upside of about 117 percent.
For more ratings news on AVI BioPharma click here and for the rating history of AVI BioPharma click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- UBS Starts Schrodinger (SDGR) at Neutral
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
